Map the system. Preserve the evidence. Test the handoff.
SiLA 2 addresses service-oriented device and system communication, Allotrope separates a scientific data format, model, and ontology, and AnIML defines an XML-based analytical-data structure. A lab architecture can use more than one, but each boundary needs an explicit version and mapping.
21 CFR 211.160 requires written laboratory controls with scientifically sound specifications, standards, sampling plans and test procedures, including quality-control-unit review and approval. A laboratory should resolve the governing approved version before sampling or testing begins and preserve any later deviation or change separately.
UniteLabs documents versioned workflows linked to runs, run inputs, logs and artifacts, plus connectors with stable identity and software version. A reconstructable laboratory run still requires the exact workflow release, connector release, device state, inputs, exceptions, and outputs to be joined rather than inferred from separate records.
21 CFR 211.160 requires written laboratory controls with scientifically sound specifications, standards, sampling plans and test procedures, including quality-control-unit review and approval. A laboratory should resolve the governing approved version before sampling or testing begins and preserve any later deviation or change separately.
UniteLabs documents versioned workflows linked to runs, run inputs, logs and artifacts, plus connectors with stable identity and software version. A reconstructable laboratory run still requires the exact workflow release, connector release, device state, inputs, exceptions, and outputs to be joined rather than inferred from separate records.
ICH Q1A(R2) connects primary batches, long-term and accelerated conditions, scheduled testing, significant-change branches, and re-test or shelf-life conclusions. A stability result is usable only inside that prospective study-arm structure.
Körber presents PAS-X as modular suites, preconfigured industry solutions, content, analytics, and services spanning development through production and packaging. Vendor content can accelerate design, but it does not become an approved site instruction until scope, version, validation, and effective use are evidenced.
TetraScience's current official page describes raw scientific files being replatformed and transformed into engineered data with taxonomies and ontologies. A laboratory still needs a reversible link to the instrument, method, processing version, sample, and qualified result before reuse or AI analysis.
Ovation presents a LIMS for molecular diagnostic laboratories and a Research Network that helps laboratories mobilize remnant samples for human-health research. Moving a remnant specimen beyond its diagnostic workflow needs a separate, reconstructable custody chain for the exact material, linked data, condition, handoff, receipt, exception, and final disposition.
A useful LIMS review traces request, sample, aliquot, specification, method, work assignment, result, exception, approval, report, and retained history. ELN and data-platform overlap does not erase that operating center.
Read the market record →Experiment authoring, entities, protocols, observations, analysis, collaboration, signatures, and intellectual-property records create a different decision surface from high-throughput sample operations.
Read the market record →Raw acquisition files, processed results, metadata, audit records, semantic models, methods, and derived datasets need explicit ownership. Archive, processing, and reuse are related but not interchangeable.
Read the market record →Worklists, device identity, method version, acquisition, transfer, exception, result review, and custody should survive the handoff among LES, CDS, LIMS, instruments, robotics, and enterprise systems.
Read the market record →Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
Laboratory-system evidence is decision-useful only when the market label, authoritative record, configured workflow, scientific data, technical control, accountable reviewer, and unresolved boundary remain visible.
The research connects the provider market, normalized capabilities, authority records, operating domains, and source limitations rather than presenting a score or universal winner.
Read the report →